Trial Profile
Specified Drug Use-Results Survey on Long-Term Treatment for Prograf Capsules 0.5 mg, 1 mg Lupus Nephritis
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 07 Apr 2020
Price :
$35
*
At a glance
- Drugs Tacrolimus (Primary)
- Indications Lupus nephritis
- Focus Therapeutic Use
- Acronyms TRUST
- Sponsors Astellas Pharma
- 01 Apr 2020 Interim Results (n=1355;data cutoff in August 2016) assessing long term safety and effectiveness of tacrolimus for treating lupus nephritits in the real world clinical setting data relating to 5 years data of tacrolimus maintenance therapy, published in The Journal of Rheumatology
- 08 Jul 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 09 Aug 2011 New trial record